发明名称 MODIFIED ADENOVIRAL VECTORS FOR USE IN GENE THERAPY
摘要 <p>The present invention provides means and methods for the generation and manufacturing of recombinant Ad vectors that are modified in E2B and/or E4 functions, preferably, said vectors comprise E1 and/or E2A deletions. For this purpose, the vector genome is modified in the respective promoter regions such that the promoter is only active in a suitable complementing cell line or only active following a certain signal in the case of an inducible promoter. The modified promoter is, on the other hand, inactive under normal conditions, and in normal mammalian and/or human cells. Hence, vectors that possess said modified promoter in the E2B and/or E4 region do not express the respective transcription region in mammalians and/or humans.</p>
申请公布号 WO2001020014(A1) 申请公布日期 2001.03.22
申请号 NL2000000640 申请日期 2000.09.11
申请人 发明人
分类号 主分类号
代理机构 代理人
主权项
地址